Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for Medinotec (MDNC) over the last 4 years, with Q4 2025 value amounting to $2.9 million.

  • Medinotec's Cash & Equivalents rose 674.01% to $2.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.9 million, marking a year-over-year increase of 674.01%. This contributed to the annual value of $2.8 million for FY2025, which is 139.64% down from last year.
  • Latest data reveals that Medinotec reported Cash & Equivalents of $2.9 million as of Q4 2025, which was up 674.01% from $2.2 million recorded in Q3 2025.
  • In the past 5 years, Medinotec's Cash & Equivalents ranged from a high of $3.6 million in Q2 2022 and a low of $131577.0 during Q1 2022
  • In the last 4 years, Medinotec's Cash & Equivalents had a median value of $2.8 million in 2024 and averaged $2.6 million.
  • Examining YoY changes over the last 5 years, Medinotec's Cash & Equivalents showed a top increase of 204889.91% in 2023 and a maximum decrease of 2393.14% in 2023.
  • Quarter analysis of 4 years shows Medinotec's Cash & Equivalents stood at $2.8 million in 2022, then decreased by 5.9% to $2.7 million in 2023, then decreased by 0.08% to $2.7 million in 2024, then rose by 6.74% to $2.9 million in 2025.
  • Its Cash & Equivalents was $2.9 million in Q4 2025, compared to $2.2 million in Q3 2025 and $2.0 million in Q2 2025.